China Finance Inc.

Dr. Ludan Liu is currently a senior analyst/trader at SAC Capital Management and specialized in global macro/emerging markets investing. Previously he worked at Deutsche Bank as an emerging market strategist. He held a Ph.D. in Finance from Boston College and B.S. in Economics from Tsinghua University. He has been serving as a TCFA director since 2000. During that period, he also served as Editor-in-Chief and was in charge of membership management. He has helped organized various TCFA events and looks forward to another opportunity to serve this organization.

Dr. Fei Zou is a vice president and portfolio manager at American Century Investments, a premier investment manager with over $100 billion under management. Dr. Zou joined American Century in 1999, and has been responsible for managing American Century's Large Cap Core strategy, Large Cap Growth strategy, and various International strategies in both long-only and long/short fashion. In addition to his portfolio management responsibilities, Dr. Zou is also responsible for developing stock selection models for a range of other strategies within the American Century Quantitative Equity Group, which manages $20 billion in a mixture of mutual funds, institution separate accounts and sub-advisory accounts for other financial institutions. Dr. Zou has served as a director and board member of TCFA from 1999 to 2004, and was the chairman of the board from 2000 to 2001. Dr. Zou received his Ph.D. in Finance and MS in Economics from the University of Texas at Austin. Dr. Fei Zou is a Chartered Financial Analyst (CFA) and is a member of CFA Institute.

Dr. Jay Luo currently is the Managing Director responsible for the Asia operations of SAC Capital Advisors, LLC, a Stamford, Connecticut based multi strategy hedge fund. Prior to joining SAC, Jay was a managing consultant at Reuters Risk Management Consulting group. He has been the TCFA Connecticut chapter chairperson before moving to Hong Kong.

Yong is a Director and a senior Portfolio Manager in the Quantitative Strategies Group of Credit Suisse Asset Management (CSAM), where he heads CSAM's U.S. quantitative equity research and products. Mr. Weng is responsible for the management of CSAM's U.S. equity long-short market-neutral fund, enhanced index funds, and other equity structured products. Mr. Weng also serves as a member of CSAM U.S. Equity Investment Policy Committee and a member of CSAM New York Product Control Committee. Before joining CSAM, Mr. Weng was a Vice President and senior quantitative analyst with Banc of America Capital Management. Mr. Weng holds a B.E. in Management Information Systems and an M.E. in Systems Engineering from Tsinghua University in Beijing, and a Ph.D. in Economics from Boston University.

Tony is the Managing Director and Head of US correlation trading at RBS Greenwich. He was also the Principal at Mariner Investment Group, a fixed income hedge fund with over 4.5B asset under management. Before his job at Mariner, he was the Director at ABN AMRO, responsible for the North American exotic trading business. He started his career on wall street at JPMorgan, while he worked as an exotic credit derivatives trader. He holds MBA from University of Chicago and MS in Physics and Computer Science from Drexel University and BS from University of Science and Technology of China. He is a Chartered Financial Analyst (CFA).

Dennis is a senior associate in Fixed Income Analytics Team at Societe Generale Corporate Investment Banking. His responsibility includes review of trading strategy and model implementation/validation across fixed income cash /derivatives product and structured finance product. Prior to SocGen, Dennis managed interest rate / credit derivatives analytics systems for IRD/Credit Derivative Division at Credit Lyonnais (Currently Calyon Corporate & Investment Banking) until 2002. Previously, Dennis did his stint with Lazard Feres Asset Management (20 billions under management) as portfolio analyst for the buy-side portfolio manager (both domestic and international fixed income/equity lines). Dennis also worked as a senior IT consultant in NYU Stern Business School back in the academic years. Dennis joined TCFA and collaborated with TCFA officer in 2005 annual conference and seminars. Dennis Chan holds BS in Electrical Engineering from University of Rochester, MS in Computer Science / Mathematic Finance from New York University and Global Executive MBA from Fordham/Peking University.

Ms. Guo joined China Finance, Inc. from the Bank of China where she served as the Assistant Manager. Prior to that she spent three years as the project manager at the China International Trust and Investment Corporation (CITIC), a transnational conglomerate providing full financial services. Ms. Guo received her MBA from University of Illinois with a concentration in Finance and is currently working on her CFA Level II certification.

Dr. Zhang is the director of Global Quantitative Finance Research at Fitch Ratings, leading the research in the area of credit derivative and structured products. He joined TCFA in 1999 and has since actively participated TCFA activities, including help organizing the 2004 and 2005 TCFA annual conferences and workshops; co-heading the TCFA company gift-matching and volunteer incentive program in the last 2 years. As the treasurer of TCFA, he sits on the TCFA Finance and Accounting committee since 2004. In this role he manages TCFA funds, prepares tax filing and maintains TCFA non-profit status with IRS. Ben has also been unofficial "post master" of TCFA. Going forward, Ben would like to contribute more towards building TCFA regular networking events for members, including blogs, online community and in-person events. Ben holds Ph.D. in Financial Economics from Duke University. Before Fitch, He works at Moody's KMV.

Dr. Guang Guo is currently a credit risk modeling research manager in the new product research group of Moody's KMV, a wholly-own subsidiary of Moody's corporation (the parent company of Moody's Investors Service). He has been employed since July, 2004. He holds a PhD in Economics fro Penn State University. His research focus is econometric modeling application in macro economy and financial market forecasting. Prior to the overseas study, he worked in the Bank of Communications, Shanghai as an investment consultant for two years after he graduated from Xiamen University with a bachelor degree in international finance.

Xiongwei is a Managing Director and Senior Portfolio Manager at Millennium Partners, a multi-strategy hedge fund. He manages a team of researchers and traders and a global portfolio dedicated to various markets neutral arbitrage strategies. Previously he was a Director at Nomura Securities International's equity proprietary trading division, where he built a quantitative market neutral arbitrage operation. Dr. Ju holds a Ph.D. in finance from University of Illinois at Urbana-Champaign.

James Xiaoan Tian is a team leader in the Listing Division of Hong Kong Stock Exchange responsible for the review and approval of IPO and listing applications in Hong Kong market. James worked in the Pubic Issuing Supervision Department of the China Securities Regulatory Commission (CSRC) responsible for approving A-share issuing and listing for substantial years, and previously worked in the Shanghai Stock Exchange (SSE), before moved to Hong Kong. As an expert in both Hong Kong and Mainland China capital markets, he has some writing published and is invited to speak in conferences quite often.

Ms. Su is a research analyst at Standish Mellon Asset Management, a leading fixed-income manager with $150 billion asset under management. She is responsible for the firm's proprietary asset allocation models as well as structure products research coverage. Liz also interned with Deutsche Asset Management Credit Research group where she conducted credit analysis covering companies in the REIT and consumer industries. Liz received her M.B.A. from MIT Sloan School of Management. Prior to MIT Sloan, Liz spent four years in economic consulting industry specializing in the Finance practice area. She has extensive experience in managing large-scale financial valuation projects spanning a variety of industries including financial services, telecommunication, energy, biotechnology and pharmaceuticals. Liz is a CFA charter holder and a member of the Boston Security Analyst Society. She received her bachelor degree in International Finance from Wuhan University and a Master degree in Economics from Tufts University.

Minghui (Henry) Jia, Managing Director and Founder Jade Pharma Inc: Mr. Jia has over 10 years of investment banking, venture capital, marketing institutional trading and senior corporate management experience. Mr. Jia is familiar with all procedures for manufacturing and marketing with respect to the Asia pharmaceutical market, and has an in-depth understanding of the industry. Over the past few years, Mr. Jia has helped several Chinese domestic pharmaceutical companies list and obtain financing in the China stock exchange market (Shenzhen) and in Hong Kong. Prior to founding Jade Capital Group Ltd and Jade Pharmaceutical Inc., Mr. Jia served as Marketing Director for China Real Estate Corporation, one of the largest Chinese property corporations, between 1999 and 2003. Between 1989 and 1998, Mr. Jia served as General Manager of several branches of China Resource Co. Ltd (CRC), the largest China export and import corporation. From 1987 to 1989, Mr. Jia worked for the China National Machinery import and export corporation where he served as Manager of the Import Department for Medical Instruments. In addition to his business and entrepreneurial activities, Mr. Jia is a Senior Editor of China Finance. Mr. Jia is fluent in Mandarin, Cantonese, English and Vietnamese. Mr. Jia received his B.A. in economics from the University of International Business and Economics of China in 1987.